Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suhail Al-Shammri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 12, 2025
Vitamin D Supplementation Mediates a Shift toward Anti-Inflammatory Cytokine Response in Multiple SclerosisSuhail Al-Shammri, Arpita Chattopadhyay, Raj Raghupathy
Frontiers in Neurology|February 24, 2025
Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosisSuhail Al-Shammri, Arpita Chattopadhyay, Abu Salim Mustafa
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|May 26, 2023
The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying TherapiesSuhail Al-Shammri, Geeti Chadha, Arpita Chattopadhyay, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjectsSuhail Al-Shammri, Hasmukh Fatania, Reem Al-Radwan, et al.
Biomedicines|July 29, 2023
Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple SclerosisSuhail Al-Shammri, Arpita Chattopadhyay, Magdy Girgis Hanah, et al.
Psychiatry Research|July 22, 2009
Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patientsAbayomi O Akanji, Jude U Ohaeri, Suhail Al-Shammri, et al.
Frontiers in Neurology|February 2, 2026
Predicting multiple sclerosis prognosis using AI and machine learning: integrating clinical, immunological, and radiological variablesSuhail Al-Shammri, Ahmet Özdil, Amro Aboukoura, et al.
The International Journal of Neuroscience|April 9, 2010
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory GroupBassem I Yamout, Maurice Dahdaleh, Mohammed Ali Al Jumah, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 12, 2025
Vitamin D Supplementation Mediates a Shift toward Anti-Inflammatory Cytokine Response in Multiple SclerosisSuhail Al-Shammri, Arpita Chattopadhyay, Raj Raghupathy
Frontiers in Neurology|February 24, 2025
Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosisSuhail Al-Shammri, Arpita Chattopadhyay, Abu Salim Mustafa
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|May 26, 2023
The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying TherapiesSuhail Al-Shammri, Geeti Chadha, Arpita Chattopadhyay, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjectsSuhail Al-Shammri, Hasmukh Fatania, Reem Al-Radwan, et al.
Biomedicines|July 29, 2023
Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple SclerosisSuhail Al-Shammri, Arpita Chattopadhyay, Magdy Girgis Hanah, et al.
Psychiatry Research|July 22, 2009
Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patientsAbayomi O Akanji, Jude U Ohaeri, Suhail Al-Shammri, et al.
Frontiers in Neurology|February 2, 2026
Predicting multiple sclerosis prognosis using AI and machine learning: integrating clinical, immunological, and radiological variablesSuhail Al-Shammri, Ahmet Özdil, Amro Aboukoura, et al.
The International Journal of Neuroscience|April 9, 2010
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory GroupBassem I Yamout, Maurice Dahdaleh, Mohammed Ali Al Jumah, et al.
Pageof 1